Table 2.
Proportion of children who received all recommended vaccine doses at ages 2 and 7 for children not in care and children in care, risk difference, and relative risk (RR) for not receiving all recommended vaccine doses, for children in care versus children not in care
| Children not in care No., % (95% CI) |
Children in care No., % (95% CI) |
Risk difference of having full number of vaccine dosesa % (95% CI) | RR of not having all vaccine dosesb RR (95% CI) |
|
|---|---|---|---|---|
| Age 2 | ||||
| n = 44,077 | n = 129 | |||
| DTaP-IPV-Hib (4 doses) | 32,724, 74.2% (73.8–74.7) | 70, 54.3% (45.7–62.9) | 20.0% (11.6–28.6) | 1.78 (1.47–2.14) |
| Men-C (3 doses) | 37,731, 85.6% (85.3–85.9) | 96, 74.4% (66.9–81.9) | 11.2% (4.4–19.4) | 1.78 (1.32–2.39) |
| MMR (1 dose) | 38,513, 87.4% (87.1–87.7) | 105, 81.4% (74.7–88.1) | 6.0% (0.2–13.6) | 1.47 (1.03–2.12) |
| Age 7 | ||||
| n = 42,028 | n = 213 | |||
| DTaP-IPV (5 doses) | 32,199, 76.6% (76.2–77.0) | 113, 53.1% (46.3–59.8) | 23.6% (17.0–30.3) | 2.01 (1.74–2.32) |
| MMR (2 doses) | 35,041, 83.4% (83.0–83.7) | 139, 65.3% (58.9–71.7) | 18.1% (12.0–24.7) | 2.09 (1.74–2.52) |
No. number, CI confidence interval, DTaP-IPV-Hib diphtheria, tetanus, pertussis, polio, Haemophilus influenzae tybe b, Men-C Meningococcal, MMR measles, mumps, rubella, DTaP-IPV diphtheria, tetanus, pertussis, polio, RR relative risk
aCalculated as risk of being vaccinated for children not in care minus children in care
bReference group = children not in care; Comparison group = children in care